Antihistamine Market Size & Share Analysis - Growth Trends & Forecast (2024-2029)

Antihistamine Market Analysis

The antihistamine market is expected to register a CAGR of 7.7% over the forecast period.

COVID-19 has significantly impacted the antihistamines market as many clinical trials and in vitro, studies have shown several antihistamines to be promising in the management of Covid19 by easing pulmonary symptoms. For instance, according to a study published in Health Science Reports in February 2023, antihistamines specific to Covid-19 have to be identified and added as a fundamental treatment method to the care plan for Covid-19, along with other techniques. They appear to be effective in treating Covid-19 while removing symptoms quickly and giving the body enough time to reset its defense mechanisms, resulting in a speedy recovery. The market has seen a slight decline during the early pandemic, due to supply chain restrictions and manufacturing halts. However, during the late pandemic, the market has attained a significant pace due to the inclusion of antihistamines in COVID-19 treatment protocols. Furthermore, the market has seen lucrative growth post-pandemic and is anticipated to show the same trend over the forecast period.

The factors driving the market growth include rising issues of allergies and stomach disorders, rising in the research and development activities for the development of novel dosage forms.

The rising issues of allergies and acid reflex are anticipated to drive the growth of the market studied over the forecast period. For instance, according to the Asthma and Allergy Foundation 2023, approximately 81 million people in the United States in 2021 were diagnosed with seasonal allergic rhinitis (hay fever) including around 26% (67 million) of adults and 19% (14 million) of children. In addition, according to the study published in Rawal Medical Journal in September 2022, the prevalence of gastroesophageal reflex disease (GERD) was found to be 18.1 to 27.8% in NorthAmerica, 8.8 to 25.9% in Europe, 2.5 to 7.8% in East Asia, 8.7 to 33.1% in MiddleEast, 11.6% in Australia and 23% in South-America. Therefore, such a huge prevalence of allergies and stomach disorders is anticipated to increase the demand for antihistamines, driving the market growth.

Furthermore, rising advancements in development of novel dosage forms of antihistamine medications and approvals from the international regulatory agencies are anticipated to bolster the market growth over the forecast period. For instance, in June 2021, The United States Food and Drug Administration approved a nasal antihistamine (Azelastine HCI .15%) developed by Bayer through a procedure known as a partial prescription to nonprescription transition for seasonal and perennial allergic rhinitis. Therefore, the approvals of antihistamines as a nonprescription medication is anticipated to increase the adoption among people, driving the market growth.

Moreover, the price control and reimbursement of antihistamine drugs are anticipated to propel the market growth further. For intance, in November 2021, Taiho Pharmaceutical Co., Ltd. and Meiji Seika Pharma Co., Ltd's Bilanoa OD Tablets 20 mg (generic name: bilastine), an oral anti-allergy drug, in Japan has been listed on National Health Insurance reimbursement price list. The listing of drugs on reimbursement price list is anticipated to rise the adoption due to reduction in prices of antihistamine drugs, thereby driving the market growth.

Therefore, the rising issues of allergies and stomach disorders, favourable reimbursement policies and rising approvals from regulatory agencies are the factors anticipated to drive the market growth. However, the patent expiry of branded drugs, introduction of generic drugs and adverse affects associated with antihistamine drugs are impeding the market growth.

Antihistamine Market Trends

Allergic Disorders in Anticipated to Hold a Significant Share in the Market Studied

Antihistamine Industry Segmentation

As per the scope of the report, antihistamines are a family of medications frequently used to treat allergy symptoms. These medications aid in the treatment of ailments brought on by an excess of histamine, a substance produced by your body's immune system. People who experience allergic reactions to pollen and other allergens are the ones who most frequently use antihistamines. They are also used to treat a wide range of other illnesses, including anxiety, colds, and gastrointestinal issues. 

The Antihistamine Market is Segmented by Drug Class (H1 Antihistamines (First Generation and Second Generation), H2 Antihistamines, and H3 Antihistamines), Dosage Form (Oral Route, Parenteral Route, and Other Dosage Forms), Type (OTC and Prescription-based), Disease (Allergic Disorders, Stomach Disorders, Central Nervous System Disorders, and Other Diseases), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the market size in value terms in USD for all the abovementioned segments.